Nanobiotix has completed the transfer of NANORAY-312 sponsorship, initiated in 3Q2024, in the majority of regions along with the transfer of full operational control of the Phase 3 clinical trial to ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
From October 17 to 21, the European Society for Medical Oncology (ESMO) Annual Congress convened in Berlin, bringing ...
In vivo, ARV-806 demonstrated robust and durable KRAS G12D degradation, leading to significant tumor growth inhibition in models of pancreatic, ...
Fertilisation technology evolves with precision slurry systems, AI-driven mineral spreaders and combination methods for ...
Everlane drops its most circular puffer yet while Haelixa adds physical proof to digital supply chain data with TextileGenesis.
Treatment was well-tolerated and injection feasibility was confirmed in 13 patients with locally advanced adenocarcinoma of the esophagus85% (11/13) disease control rate (DCR)69% (9/13) objective ...
Danaher Corporation ( NYSE: DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Cells at the bottom of a liquid medium begin levitating, then hovering at a particular height. With no physical contact, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback